Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
Contin
Manueala
M
Martinelli
Paolo
P
Albani
Fiorenzo
F
Scaglione
Cesa
C
Avoni
Patrizia
P
Rizzo
Giovanni
G
Baruzzi
Agostino
A
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D007980:Levodopa / Q000009:adverse effects / Q000097:blood; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000097:blood / Q000188:drug therapy*; D010889:Piracetam / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D018709:Statistics, Nonparametric
D000978:Antiparkinson Agents; D018697:Nootropic Agents; D000077287:Levetiracetam; D007980:Levodopa; D010889:Piracetam